03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Split along partisan lines, the Federal Trade Commission (Commission) voted last week to issue Comme...
Read More >
A new law has taken effect that makes significant changes to the rules for making contributions to a...
Read More >
2019 has brought a flurry of new leave and accommodation laws. In fact, in the first 8 months of 20...
Read More >
The day-to-day professional and personal impact of the COVID-19 pandemic is substantial. The global...
Read More >
The Department of Labor (DOL) issued a final rule last weekend that codifies a majority of the chang...
Read More >
Q: Over the summer, I saw that President Trump tweeted that four minority Democrat congresswomen sho...
Read More >